// COMPANY
Link Cell Therapies
SECTOR BIOTECHMENTIONS 2LAST SEEN SEPTEMBER 30, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·StrictlyVC·SEPTEMBER 30, 2026
“Link Cell Therapies, CAR-T developer using marker-combination activation, raised a $30 million Series A round led by Johnson & Johnson with BMS participation.”
Source→02
funding·PitchBook News·SEPTEMBER 30, 2026
“Link Cell Therapies raised an additional $30 million for its Series A led by Johnson & Johnson.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.